| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 98.33B | 103.73B | 98.26B | 124.86B | 123.90B | 119.32B |
| Gross Profit | 22.91B | 24.97B | 22.66B | 25.31B | 24.18B | 22.51B |
| EBITDA | 8.55B | 9.80B | 8.29B | 10.13B | 7.91B | 7.18B |
| Net Income | 5.04B | 6.47B | 4.76B | 5.48B | 3.52B | 2.80B |
Balance Sheet | ||||||
| Total Assets | 75.55B | 87.63B | 81.07B | 81.07B | 83.21B | 79.23B |
| Cash, Cash Equivalents and Short-Term Investments | 41.30B | 43.47B | 38.71B | 38.70B | 20.88B | 19.16B |
| Total Debt | 9.42B | 8.39B | 9.55B | 10.19B | 10.99B | 12.51B |
| Total Liabilities | 31.57B | 38.79B | 36.44B | 40.20B | 47.82B | 46.02B |
| Stockholders Equity | 43.57B | 48.31B | 44.16B | 40.40B | 34.95B | 32.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.07B | 3.13B | 4.01B | 3.17B | 3.69B |
| Operating Cash Flow | 0.00 | 6.32B | 3.41B | 4.95B | 4.26B | 5.56B |
| Investing Cash Flow | 0.00 | 1.71B | -792.00M | 15.47B | 39.00M | -4.00M |
| Financing Cash Flow | 0.00 | -3.27B | -2.60B | -2.61B | -2.61B | -2.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥66.66B | 9.74 | ― | 2.82% | 5.56% | 35.28% | |
78 Outperform | ¥50.24B | 11.52 | ― | 3.48% | 15.87% | 4.49% | |
77 Outperform | ¥59.44B | 5.85 | 16.91% | 2.28% | 8.57% | 43.80% | |
75 Outperform | ¥40.94B | 16.04 | ― | 1.90% | 14.03% | 48.65% | |
64 Neutral | ¥58.11B | 35.18 | ― | 1.52% | 24.74% | -18.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥20.99B | 9.16 | ― | 3.66% | -10.58% | 15.99% |